$2.76 -0.32 (-10.39%)
2/10/2012 4:00 PM

Corcept Therapeutics, Inc. (NASDAQ:CORT)

CAPS Rating: 2 out of 5

A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.

Featured Broker Partners


Advertisement